BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9657508)

  • 1. Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosus.
    Cobo F; Yarnoz C; Sesma B; Fraile P; Aizcorbe M; Trujillo R; Diaz-de-Liaño A; Ciga MA
    Trop Med Int Health; 1998 Jun; 3(6):462-6. PubMed ID: 9657508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chemotherapeutic agents in the management of cystic echinococcosis.
    Nazligul Y; Kucukazman M; Akbulut S
    Int Surg; 2015 Jan; 100(1):112-4. PubMed ID: 25594649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined praziquantel and albendazole chemoprophylaxis in experimental hydatidosis.
    Casado N; Urrea-París MA; Moreno MJ; Rodríguez-Caabeiro F
    Parasitol Res; 2001 Sep; 87(9):787-9. PubMed ID: 11570568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes.
    Torabi N; Dobakhti F; Faghihzadeh S; Haniloo A
    Parasitol Res; 2018 Jul; 117(7):2015-2023. PubMed ID: 29616349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praziquantel and albendazole in the combined treatment of experimental hydatid disease.
    Moreno MJ; Urrea-París MA; Casado N; Rodriguez-Caabeiro F
    Parasitol Res; 2001 Mar; 87(3):235-8. PubMed ID: 11293572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term evaluation of patients with hydatidosis treated with albendazole and praziquantel.
    Haralabidis S; Diakou A; Frydas S; Papadopoulos E; Mylonas A; Patsias A; Roilides E; Giannoulis E
    Int J Immunopathol Pharmacol; 2008; 21(2):429-35. PubMed ID: 18547489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Albendazole and Praziquantel therapy of Echinococcus granulosus in naturally infected sheep.
    Morris DL; Richards KS; Clarkson MJ; Taylor DH
    Vet Parasitol; 1990 May; 36(1-2):83-90. PubMed ID: 2382392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
    Gavidia CM; Gonzalez AE; Barron EA; Ninaquispe B; Llamosas M; Verastegui MR; Robinson C; Gilman RH
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e616. PubMed ID: 20186332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echinococcus multilocularis: in vivo results of therapy with albendazole and praziquantel.
    Taylor DH; Morris DL; Richards KS; Reffin D
    Trans R Soc Trop Med Hyg; 1988; 82(4):611-5. PubMed ID: 3076717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
    Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
    Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
    Lötsch F; Naderer J; Skuhala T; Groger M; Auer H; Kaczirek K; Waneck F; Ramharter M
    Parasitol Res; 2016 Aug; 115(8):2995-3001. PubMed ID: 27085708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: clinical and serological evaluation of echinococcosis of the spine.
    El-On J; Ben-Noun L; Galitza Z; Ohana N
    Trans R Soc Trop Med Hyg; 2003; 97(5):567-9. PubMed ID: 15307428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of albendazole, mebendazole and praziquantel chemotherapy of Echinococcus multilocularis in a gerbil model.
    Taylor DH; Morris DL; Reffin D; Richards KS
    Gut; 1989 Oct; 30(10):1401-5. PubMed ID: 2583567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of cystic echinococcosis: systematic review and meta-analysis.
    Velasco-Tirado V; Alonso-Sardón M; Lopez-Bernus A; Romero-Alegría Á; Burguillo FJ; Muro A; Carpio-Pérez A; Muñoz Bellido JL; Pardo-Lledias J; Cordero M; Belhassen-García M
    BMC Infect Dis; 2018 Jul; 18(1):306. PubMed ID: 29976137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of hydatid disease of the liver: Part 2.
    Fenton-Lee D; Morris DL
    Trop Doct; 1997 Apr; 27(2):87-8. PubMed ID: 9133790
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects in medical management of Echinococcus granulosus.
    Yasawy MI; Alkarawi MA; Mohammed AR
    Hepatogastroenterology; 2001; 48(41):1467-70. PubMed ID: 11677989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echinococcus multilocularis: ultrastructural effect of in vivo albendazole and praziquantel therapy, singly and in combination.
    Richards KS; Morris DL; Taylor DH
    Ann Trop Med Parasitol; 1989 Oct; 83(5):479-84. PubMed ID: 2694979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatment.
    Jamshidi M; Mohraz M; Zangeneh M; Jamshidi A
    Parasitol Res; 2008 Jun; 103(1):195-9. PubMed ID: 18404278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary muscle hydatidosis of the thigh: management of a complicated case with combination adjunctive albendazole and praziquantel chemotherapy.
    Thursky K; Torresi J
    Clin Infect Dis; 2001 Feb; 32(3):E65-8. PubMed ID: 11170975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.